BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8212715)

  • 21. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study.
    Rosenthal T; Grossman E; Rathaus M; Bernheim J; Zevin D; Levi J; Weinstein J; Rogel S
    Isr J Med Sci; 1990 Feb; 26(2):63-6. PubMed ID: 2180849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of mild and moderate hypertension with enalapril (multicenter study of enap and enap N in Ukraine)].
    Dziak GV; Kolomiets SN; Minakov AI; Fushteĭ IM; Iavorskiĭ OG; Bekker VF; Vankhanen VN; Davydova IV; Zaĭtseva VI; Kolesnik TV; Kolomiets VV; Svishchenko EP; Taran AI; Shlykova NA; Barbich-Zhagar B
    Ter Arkh; 1999; 71(1):31-4. PubMed ID: 10097297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and tolerability of enalapril--hydrochlorothiazide combination as a first line therapy in black patients with mild to moderate arterial hypertension: a clinical study in Kenya.
    Lore W; Muita AK; Ogola ES
    East Afr Med J; 1992 Jan; 69(1):18-21. PubMed ID: 1628542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure].
    Mayaudon H; Chanudet X; Janin G; Madonna O
    Ann Cardiol Angeiol (Paris); 1995 May; 44(5):235-41. PubMed ID: 7639505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of efficacy of the enalapril-hydrochlorothiazide combination by ambulatory blood pressure monitoring in essential hypertensive patients].
    Oigman W; Spritzer N; Introcaso L; Santello JL
    Arq Bras Cardiol; 1993 Feb; 60(2):123-7. PubMed ID: 8240048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril maleate and atenolol combined with hydrochlorothiazide in moderate to severe essential hypertension.
    Pascoe J; Moon R; Gray D; Musgrove J
    N Z Med J; 1985 Nov; 98(790):951-3. PubMed ID: 3001605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rest and exercise hemodynamic and adrenergic responses to enalapril, hydrochlorothiazide, and combination treatment in patients with systemic hypertension.
    Stroh JA; Saltzberg S; Weinberg P; Shamoon H; Charlap S; Frishman W
    J Clin Hypertens; 1985 Mar; 1(1):35-48. PubMed ID: 3014075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enalapril as first choice treatment of mild, moderate and severe essential hypertension: results of an open multicentre clinical trial. New Zealand Hypertension Study Group.
    N Z Med J; 1987 Mar; 100(819):137-9. PubMed ID: 2837697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
    Fernandez PG; Kim BK; Galway AB
    Pharmatherapeutica; 1984; 3(8):505-14. PubMed ID: 6322207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enalapril in essential arterial hypertension].
    Barría MS; Plubins L; Rodríguez MS; Alvo M; Nuñez G; Vega C; Gonzalez H; Faivovich A; Gonzalez F; Domic H
    Rev Med Chil; 1989 Jun; 117(6):667-70. PubMed ID: 2562413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term antihypertensive, metabolic and cellular effects of enalapril.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    J Hypertens Suppl; 1984 Dec; 2(2):S101-5. PubMed ID: 6100870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.